The evidence that oxidative lipid
Introduction
"The great tragedy of Science -the slaying of a beautiful hypothesis by an ugly fact."
T.H. Huxley Collected Essays (1893-1894) Biogenesis and Abiogenesis
The possible role of lipid modification in atherogenesis has been argued for several years [1] . The 'lipid oxidation' hypothesis is supported by several strands of evidence, including experimental animal models, in vitro studies, and observational studies in man. Supporting clinical trial results, using antioxidant intervention, has been more elusive [2] . In part, this is due to the complexity of the systems involved, the uncertainty about the optimum doses of any particular antioxidant, and which combination of water-and lipidsoluble antioxidants should be used.
Low-density lipoproteins (LDLs) and high-density lipoprotein (HDLs) can be modified in several ways and to different degrees. Oxidative modification is one form of modification, and changes the properties of LDLs and HDLs in ways that are considered to promote atherogenesis [1, [3] [4] [5] .
Co-incubation studies have demonstrated that several cell types can modify LDL in vitro, but the mechanisms by which they do so are still uncertain. The existence and pathophy-paraoxonase 1. 1 To whom correspondence should be addressed (e-mail g.ferns@surrey.ac.uk).
siological importance of oxidized LDL in vivo has been supported by studies using experimental animal models and human material. Lipoprotein particles with physicochemical properties similar to oxidized LDL are present in human atherosclerotic lesions. These particles appear to be recognized as foreign, since circulating antibodies to oxidized LDL have been reported to be present in individuals with established atherosclerosis [6] or with coronary dysfunction [7] .
Effects of oxidation on lipoprotein constituents
The oxidation of LDL and HDL in vitro leads progressively from native LDL or HDL to highly modified forms that differ in their chemical composition (Table 1) . During this process the unsaturated fatty acid constituents of the lipoprotein are oxidized, leading to the formation of lipid hydroperoxides. This appears to occur at different rates for the different fatty acids within phospholipids and cholesteryl esters [8] . The various forms of oxidized LDL have differential effects on macrophage and endothelial-cell gene expression [8] [9] [10] . The prediction of how these cells might respond in vivo is complicated further by the fact that the various products of LDL oxidation may have opposing effects on gene expression [9, 10] . Furthermore, although products of LDL oxidation, such as lysophosphatidylcholine, are potentially pro-atherogenic [9] , they may give rise to compensatory beneficial responses, such as an upregulation of antioxidant enzyme activity [11] .
HDLs are more susceptible to oxidation than LDLs. The kinetics of the reaction were found to be similar to those observed for LDL oxidation, with a rapid accumulation of oxidation products, via an auto-catalytic phase, preceded by a lag phase [12] . Oxidized HDLs have a number of potentially important biological effects, including activation of nuclear factor κB, which is thought to be mediated via its binding to LOX-1, the oxidized LDL receptor 1, on the cell surface, followed by enhancement of intracellular reactive oxygen species production in endothelial cells [13] . The oxidation of HDLs is also accompanied by a reduction in paraoxonase 1 (PON1) activity, with the extent of PON1 inactivation depending both on the extent of HDL oxidation and on the oxidation system used [14] . HDL-associated PON1 activity has the potential to play an important antioxidant role [15] . Several mechanisms of lipoprotein modification have been proposed (Table 2) ; however, it is likely that a combination of mechanisms account for the modification of LDL and HDL in vivo.
Role of antioxidants
It is likely that there is a synergistic interplay between the water-and lipid-soluble antioxidants, and between these antioxidant compounds and the antioxidant enzymes. The efficiency of these protective systems will, in part, depend on their relative local concentrations, and the type of oxidant stress to which they are exposed. The products of tocopherol oxidation vary with the oxidant stress. In human atherosclerotic lesions, α-tocopherylquinone appears to be the major oxidation product, although unoxidized α-tocopherol remains the predominant form of vitamin E [16] , even within advanced lesions, this despite the increasing accumulation within plaque tissue of oxidized lipids with advancing disease [17] . It has been proposed that tocopherol-mediated lipid peroxidation may occur under certain conditions (reviewed by Upston et al. [18] ).
The pattern of oxidized amino acids in proteins isolated from atherosclerotic lesions implicates reactive intermediates generated by myeloperoxidase, a major phagocyte enzyme. These intermediates include hypochlorous acid, tyrosyl radical and reactive nitrogen species, each of which generates a different pattern of stable end products. Despite the evidence that myeloperoxidase promotes LDL oxidation in vivo, the antioxidant that has been tested most extensively in clinical trials, vitamin E, fails to inhibit myeloperoxidase pathways in vitro.
Clinical studies
The evidence for a role of lipid oxidation in atherogenesis, and the possible protective function of antioxidants, originally came from observational studies [19] . Since then, several other observational and intervention studies have investigated the relationship between antioxidants and coronary disease (Table 3) . Cohort studies reported a striking benefit of low doses of vitamin E supplements in healthy individuals [20, 21] , and this was followed by a study demonstrating, for the first time, that moderate doses of vitamin E supplements may be of benefit in secondary prevention [22] . However, more recent studies in high-risk groups have not shown significant benefit of vitamin E or other antioxidants [23] [24] [25] [26] [27] [28] [29] [30] [31] . Furthermore, there is no evidence of beneficial effects of α-tocopherol or β-carotene supplements in male smokers with angina pectoris [32] . However, an inverse association has been reported between the intake and plasma concentration of vitamin E, and preclinical carotid atherosclerosis in middle-aged women. This association was independent of other cardiovascular risk factors, was not related to vitamin supplements, and supports the hypothesis that a low vitamin E intake is a risk factor for early atherosclerosis [33] . In clinically healthy, hypercholesterolaemic men, with normal vitamin C and E levels, oral supplementation with a reasonable dose of vitamin E was found to lower levels of lipid peroxides in plasma, but a relatively high dose of vitamin C did not [34, 35] , which highlights the possible differential effects of these two antioxidants in vivo.
Conclusions
Despite there being considerable evidence supporting a role for lipid oxidation in atherogenesis, it has not been possible to identify a robust antioxidant intervention strategy that reproducibly prevents clinical events. Although this does not disprove the 'oxidation hypothesis,' we are left with the challenge of successfully applying it. G.A.A.F. and D.J.L. thank the British Heart Foundation for the funding of their research.
